Jeffrey G. Lamothe Aptevo Therapeutics Inc. (APVO) insider trading activity
Jeffrey G. Lamothe is EVP, COO of Aptevo Therapeutics Inc.. Currently has a direct ownership of 6 shares of APVO, which is worth approximately $13. The most recent transaction as insider was on Jul 17, 2025, when has been sold 5 shares (Common Stock (post-reverse split May ACTIVE)) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
6
83.33%
3M change
99.49%
12M change
Total Value Held
$13
Jeffrey G. Lamothe Transaction History
JGL
Jeffrey G. Lamothe
EVP, COO
Seattle, WA